abstract |
Disclosed is the use of dehydroepiandrosterone salicylate in the treatment of skin atrophy. <IMAGE> Such types skin atrophy to be treated include the thinning and/or general degradation of the dermis often characterized by a decrease in collagen and/or elastin as well as decreased number, size and doubling potential of fibroblast cells. |